Ramakrishnan S, Nicolau DV Jr, Langford B, et al. Inhaled budesonide in the treatment of
early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir
Med 2021; published online April 9. https://doi. org/10.1016/S2213-2600 (21) 00160-0—In
this Article, the findings section of the summary should have read,“For the per-protocol
population (n= 139), the primary outcome occurred in ten (14%) of 70 participants in the
usual care group and one (1%) of 69 participants in the budesonide group”. Additionally, in …

Lancet Respir Med2021; published online Jan 8. https://doi. org/10.1016/S2213-2600 (20)
30552-X—In the list of COVID-19 Intensive Care International Study Group members and
appendix 3 of this Article, the names of Isabel Torres and Viviane Hidalgo-Cabalín were
spelled incorrectly. These corrections have been made to the online version as of Jan 27
2021, and will be made to the printed version.

Abstract Aman J, Duijvelaar E, Botros L, et al. Imatinib in patients with severe COVID-19: a
randomised, double-blind, placebo-controlled, clinical trial. Lancet Respir Med 2021;
published online June 17. https://doi. org/10.1016/S2213-2600 (21) 00237-X—In this Article,
the authors Elisabeth CW Neefjes', Jeroen N Wessel's, Carolina C Pamplona's, and Elise
MA Slob's names were incorrect. Rianne JA Hoek's affiliation should have been
“Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam …

AB received research funding from Pfizer and Medtronic as well as speaker honoraria from
Bayer, Boehringer Ingelheim, Edwards, Medtronic and Novartis. KDR received a research
grant from Daiichi-Sankyo Europe GmbH. UM received fees for participation in a data and
safety monitoring board from Thermosome. All other authors declare no competing interests.

Article, Tristan Morichau-Beauchant should have been listed as an author and François
Stephan should have been included in the Paris ECMOCOVID-19 investigators list. These
corrections have been made to the online version as of June 29, 2021, and the printed
version is correct.

Lancet Respir Med 2022; published online Feb 25. https://doi. org/10.1016/S2213-2600 (22)
00045-5—We now offer open access for authors based at JISC-participating UK institutions
for papers accepted after Jan 1, 2022. As a result, the copyright license for this Article has
been updated to CC BY. This correction has been made to the online version as of April 12,
2022, and will be made to the printed version.